NCT02389374View on ClinicalTrials.gov

A Study to Assess Safety of Current Standard Malaria Treatment and an Assessment of G6PD Status in South-east Bangladesh

PHASE4CompletedINTERVENTIONAL
Enrollment

181

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Malaria
Interventions
DRUG

chloroquine

standard dose

DRUG

Artemether-lumefantrine combination

standard dose

DRUG

Primaquine

single dose

DRUG

Primaquine

14 days

All Listed Sponsors
collaborator

International Centre for Diarrhoeal Disease Research, Bangladesh

OTHER

lead

Menzies School of Health Research

OTHER

NCT02389374 - A Study to Assess Safety of Current Standard Malaria Treatment and an Assessment of G6PD Status in South-east Bangladesh | Biotech Hunter | Biotech Hunter